Citigroup’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28.8K | Buy |
31,294
+18,061
| +136% | +$21.9K | ﹤0.01% | 4716 |
|
|
2025
Q4 | $16.9K | Sell |
13,233
-5,792
| -30% | -$7.78K | ﹤0.01% | 4914 |
|
|
2025
Q3 | $24.7K | Sell |
19,025
-109,231
| -85% | -$143K | ﹤0.01% | 4752 |
|
|
2025
Q2 | $154K | Sell |
128,256
-96,571
| -43% | -$107K | ﹤0.01% | 4185 |
|
|
2025
Q1 | $243K | Sell |
224,827
-23,028
| -9% | -$32.3K | ﹤0.01% | 4087 |
|
|
2024
Q4 | $434K | Buy |
247,855
+17,230
| +7% | +$32.1K | ﹤0.01% | 3933 |
|
|
2024
Q3 | $445K | Buy |
230,625
+154,691
| +204% | +$303K | ﹤0.01% | 3797 |
|
|
2024
Q2 | $134K | Sell |
75,934
-600,242
| -89% | -$1.47M | ﹤0.01% | 4076 |
|
|
2024
Q1 | $1.83M | Buy |
676,176
+352,604
| +109% | +$851K | ﹤0.01% | 2505 |
|
|
2023
Q4 | $715K | Buy |
323,572
+133,781
| +70% | +$286K | ﹤0.01% | 3115 |
|
|
2023
Q3 | $550K | Buy |
+189,791
| New | +$496K | ﹤0.01% | 2988 |
|
|
2023
Q1 | – | Sell |
-61
| Closed | -$71 | – | 5697 |
|
|
2022
Q4 | $71 | Sell |
61
-5
| -8% | -$6 | ﹤0.01% | 5654 |
|
|
2022
Q3 | $0 | Sell |
66
-1,724
| -96% | -$2.61K | ﹤0.01% | 6101 |
|
|
2022
Q2 | $3K | Sell |
1,790
-3,815
| -68% | -$9.44K | ﹤0.01% | 5783 |
|
|
2022
Q1 | $20K | Sell |
5,605
-15,323
| -73% | -$52.9K | ﹤0.01% | 5143 |
|
|
2021
Q4 | $82K | Sell |
20,928
-94,480
| -82% | -$442K | ﹤0.01% | 4827 |
|
|
2021
Q3 | $761K | Sell |
115,408
-3,519
| -3% | -$23.2K | ﹤0.01% | 3296 |
|
|
2021
Q2 | $733K | Buy |
118,927
+113,256
| +1,997% | +$605K | ﹤0.01% | 3450 |
|
|
2021
Q1 | $26K | Sell |
5,671
-27,893
| -83% | -$153K | ﹤0.01% | 5097 |
|
|
2020
Q4 | $201K | Buy |
33,564
+30,173
| +890% | +$198K | ﹤0.01% | 4981 |
|
|
2020
Q3 | $25K | Sell |
3,391
-6,150
| -64% | -$42.5K | ﹤0.01% | 6028 |
|
|
2020
Q2 | $38K | Sell |
9,541
-33,889
| -78% | -$118K | ﹤0.01% | 6192 |
|
|
2020
Q1 | $110K | Buy |
43,430
+29,187
| +205% | +$95.9K | ﹤0.01% | 5266 |
|
|
2019
Q4 | $50K | Buy |
14,243
+8,095
| +132% | +$28.5K | ﹤0.01% | 6306 |
|
|
2019
Q3 | $28K | Sell |
6,148
-32,434
| -84% | -$255K | ﹤0.01% | 6524 |
|
|
2019
Q2 | $475K | Buy |
38,582
+28,894
| +298% | +$368K | ﹤0.01% | 4477 |
|
|
2019
Q1 | $128K | Buy |
9,688
+2,797
| +41% | +$29.5K | ﹤0.01% | 5517 |
|
|
2018
Q4 | $60K | Sell |
6,891
-399
| -5% | -$3.11K | ﹤0.01% | 6088 |
|
|
2018
Q3 | $55K | Buy |
7,290
+3,520
| +93% | +$25K | ﹤0.01% | 6448 |
|
|
2018
Q2 | $22K | Buy |
3,770
+2,778
| +280% | +$15.8K | ﹤0.01% | 6868 |
|
|
2018
Q1 | $6K | Sell |
992
-343
| -26% | -$2.25K | ﹤0.01% | 7168 |
|
|
2017
Q4 | $8K | Buy |
1,335
+1,238
| +1,276% | +$6.78K | ﹤0.01% | 7110 |
|
|
2017
Q3 | $0 | Buy |
97
+23
| +31% | +$97 | ﹤0.01% | 7344 |
|
|
2017
Q2 | $0 | Sell |
74
-144
| -66% | -$683 | ﹤0.01% | 7416 |
|
|
2017
Q1 | $1K | Buy |
+218
| New | +$1.38K | ﹤0.01% | 7086 |
|
|
2016
Q4 | – | Sell |
-2,557
| Closed | -$20K | – | 7254 |
|
|
2016
Q3 | $20K | Sell |
2,557
-545
| -18% | -$5K | ﹤0.01% | 6211 |
|
|
2016
Q2 | $28K | Sell |
3,102
-20,648
| -87% | -$194K | ﹤0.01% | 5950 |
|
|
2016
Q1 | $192K | Buy |
23,750
+14,883
| +168% | +$107K | ﹤0.01% | 5128 |
|
|
2015
Q4 | $96K | Buy |
8,867
+8,791
| +11,567% | +$86.3K | ﹤0.01% | 5403 |
|
|
2015
Q3 | $1K | Sell |
76
-41,427
| -100% | -$652K | ﹤0.01% | 7174 |
|
|
2015
Q2 | $1M | Buy |
41,503
+39,964
| +2,597% | +$1.26M | ﹤0.01% | 3157 |
|
|
2015
Q1 | $65K | Sell |
1,539
-3,277
| -68% | -$130K | ﹤0.01% | 5358 |
|
|
2014
Q4 | $162K | Buy |
4,816
+3,782
| +366% | +$107K | ﹤0.01% | 4857 |
|
|
2014
Q3 | $25K | Buy |
1,034
+720
| +229% | +$20.2K | ﹤0.01% | 5758 |
|
|
2014
Q2 | $9K | Sell |
314
-3,736
| -92% | -$120K | ﹤0.01% | 6214 |
|
|
2014
Q1 | $178K | Sell |
4,050
-4,918
| -55% | -$216K | ﹤0.01% | 4442 |
|
|
2013
Q4 | $343K | Buy |
8,968
+8,657
| +2,784% | +$255K | ﹤0.01% | 4154 |
|
|
2013
Q3 | $7K | Buy |
311
+78
| +33% | +$1.53K | ﹤0.01% | 6330 |
|
|
2013
Q2 | $4K | Buy |
+233
| New | +$4.09K | ﹤0.01% | 6383 |
|
Other funds holding LAB
CC
MCO
LFCM
VCM
HBWM
Citigroup's LAB Position: Q1 2026 in Review
Citigroup increased its Standard BioTools (LAB) stake by 136% in Q1 2026, buying an estimated $21.9K and bringing the position to 31,294 shares worth $28.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4716.
Citigroup first reported a position in LAB in Q2 2013 and has held it in 49 quarters since. The position peaked at $1.83M in Q1 2024. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.
- Citigroup held 31,294 shares of Standard BioTools worth $28.8K as of Q1 2026.
- Citigroup bought 18,061 Standard BioTools shares in Q1 2026, an estimated $21.9K.
- Standard BioTools made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4716 holding.
- Citigroup first reported a position in Standard BioTools in Q2 2013 and has held it in 49 quarters since.
- Citigroup's Standard BioTools position peaked at $1.83M in Q1 2024.
- 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.